Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Detroit, Michigan


Purpose:

This study will compare the safety and efficacy of Medidur FA treatment in one eye to the sham-treated fellow eye of subjects with geographic atrophy secondary to AMD.


Criteria:

Inclusion Criteria: - Clinical diagnosis bilateral GA secondary to AMD of ≥ 0.5 and ≤ 7 MPS disc areas - Males and non-pregnant females 55 years old or older Exclusion Criteria: - GA secondary to any condition other than AMD in either eye - History of or current CNV in either eye or the need for anti-angiogenic therapy - Glaucoma or ocular hypertension (IOP > 21 mmHg OR concurrent therapy at screening with IOP-lowering agents) in either eye - Treatment with intravitreal, subtenon, or periocular steroid within 6 months prior to enrollment in either eye - Any change in systemic steroid therapy within 3 months of screening - History of vitrectomy in either eye - Any ocular surgery within 12 weeks of screening in either eye


NCT ID:

NCT00695318


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Detroit, Michigan
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.